Pluristem Therapeutics Company

A biotechnology company using placental mesenchymal stem cells to develop cell therapies for medical conditions such as inflammation, ischemia, hematological disorders, and radiation.
Technology: SpaceTech
Industry: Cell Therapy
Headquarters: Haifa, Hefa, Israel
Founded Date: 2003
Employees Number: 5001-10000
Funding Status: IPO
Investors Number: 2
Total Funding: 162494975
Estimated Revenue: Less than $1M
Last Funding Date: 2021-02-02
Last Funding Type: Post-IPO Equity

Visit Website
info@pluristem.com
http://twitter.com/Pluristem
Register and Claim Ownership